Dashboard
Manage Tickers

STXS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

roth-capital-reiterates-buy-on-stereotaxis-maintains-4-price-target
Roth Capital Reiterates Buy on Stereotaxis...
11/12/2025 17:45:26

Roth Capital analyst Kyle Bauser reiterates Stereotaxis (AMEX:STXS) with a Buy and maintains $4 price target.

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/12/2025 12:05:51

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/11/2025 21:07:32

stereotaxis-q3-eps-007-misses-006-estimate-sales-7464m-miss-8375m-estimate
Stereotaxis Q3 EPS $(0.07) Misses $(0.06) ...
11/11/2025 21:07:01

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) b...

earnings-scheduled-for-november-11-2025
Earnings Scheduled For November 11, 2025
11/11/2025 11:11:20

stereotaxis-granted-fda-510k-for-its-genesisxrmn-system-with-navigant-workstation-and-cardiodrive-as-substantially-equivalent
Stereotaxis Granted FDA 510(k) For Its Gen...
11/10/2025 17:43:48

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K251792

a-look-at-stereotaxiss-upcoming-earnings-report
A Look at Stereotaxis's Upcoming Earnings ...
11/10/2025 16:04:07

roth-capital-reinstates-buy-on-stereotaxis-announces-4-price-target
Roth Capital Reinstates Buy on Stereotaxis...
11/05/2025 17:31:16

Roth Capital analyst Kyle Bauser reinstates Stereotaxis (AMEX:STXS) with a Buy and announces $4 price target.

stereotaxis-receives-ce-mark-seeks-fda-approval-for-synchrony-surgical-robotics-system
Stereotaxis Receives CE Mark, Seeks FDA Ap...
10/15/2025 11:35:59

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

stereotaxis-enters-collaboration-agreement-to-advance-robotic-pulsed-field-ablation-for-cardiac-arrhythmias
Stereotaxis Enters Collaboration Agreement...
10/13/2025 11:38:53

new-robotic-system-promises-faster-safer-care-for-arrhythmia-patients
New Robotic System Promises Faster, Safer ...
09/22/2025 14:05:15

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endo...

stereotaxis-genesis-robotic-magnetic-navigation-system-used-in-first-procedures-by-physicians-at-erasmus-university-mc-in-netherlands
Stereotaxis' Genesis Robotic Magnetic Navi...
09/22/2025 11:59:51

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

stereotaxis-q2-eps-005-beats-007-estimate-sales-8798m-beat-7750m-estimate
Stereotaxis Q2 EPS $(0.05) Beats $(0.07) E...
08/07/2025 20:03:17

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by ...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

stereotaxis-receives-fda-510k-clearance-for-magic-sweep-catheter
Stereotaxis Receives FDA 510(k) Clearance ...
07/28/2025 11:49:22

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

stereotaxis-announces-125m-registered-direct-offering-of-common-stock-at-200-per-share
Stereotaxis Announces $12.5M Registered Di...
07/17/2025 12:33:06

Led by Strategic Industry Partner and Select Institutional InvestorsProceeds Strengthen Balance Sheet and Support Commercializa...

stereotaxis-publishes-first-clinical-results-from-magic-catheter-study-in-journal-of-interventional-cardiac-electrophysiology
Stereotaxis Publishes First Clinical Resul...
07/01/2025 13:03:41

stereotaxis-q1-eps-007-inline-sales-747m-beat-688m-estimate
Stereotaxis Q1 EPS $(0.07), Inline, Sales ...
05/12/2025 20:05:32

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 16.6...

Core News & Articles
Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

whats-going-on-with-stereotaxis-shares-wednesday
What's Going On With Stereotaxis Shares We...
03/19/2025 19:06:20

Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION